Geskin, L., Querfeld, C., Hodak, E., Nikbakht, N., Papadavid, E., Ardigò, M., Wehkamp, U., & Bagot, M. (2024). Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians. Dermatology and Therapy. https://doi.org/10.1007/s13555-024-01305-x

Suhl, S., Lapolla, B., Kaminsky, A., & Geskin, L. J. (2025). Treatment of Sezary syndrome with combination romidepsin and tofacitinib: A case report. JAAD Case Reports, 55, 69–72. https://doi.org/10.1016/j.jdcr.2024.11.007

Adeuyan, O., Trager, M. H., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Fahmy, L. M., Chen, C., Magro, C. M., & Geskin, L. J. (2024). A unique case of paraneoplastic lymphomatoid Papuloerythroderma of Ofuji with atypical clinical features. JAAD Case Reports, 50, 102–107. https://doi.org/10.1016/j.jdcr.2024.02.009

Vadivel, C. K., Willerslev-Olsen, A., Namini, M. R. J., Zeng, Z., Yan, L., Danielsen, M., Gluud, M., Pallesen, E. M. H., Wojewoda, K., Osmancevic, A., Hedebo, S., Chang, Y.-T., Lindahl, L. M., Koralov, S. B., Geskin, L. J., Bates, S. E., Iversen, L., Litman, T., Bech, R., … Buus, T. B. (2024). Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome. Blood, 143(15), 1496–1512. https://doi.org/10.1182/blood.2023021671

Dar, N., Roberts, N., Gru, A., Obiorah, I., Zheng, J., Shields, L. K., Cropley, T., & Marchi, E. (2024). Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet. JAAD Case Reports, 48, 18–22. https://doi.org/10.1016/j.jdcr.2024.03.016

Gordon, E. R., Adeuyan, O., Kwinta, B. D., Schreidah, C. M., Fahmy, L. M., Queen, D., Trager, M. H., Magro, C. M., & Geskin, L. J. (2024). Exploring cutaneous lymphoproliferative disorders in the wake of COVID‐19 vaccination. Skin Health and Disease, 4(3). Portico. https://doi.org/10.1002/ski2.367

Pemmaraju, N., Cuglievan, B., Lasky, J., Kheradpour, A., Hijiya, N., Stein, A. S., Meshinchi, S., Mullen, C. A., Angelucci, E., Vinti, L., Mughal, T. I., & Pawlowska, A. B. (2024). Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients. EJHaem, 5(1), 61–69. Portico. https://doi.org/10.1002/jha2.856

Olsen, E. A., Hodak, E., Geskin, L., & Scarisbrick, J. (2024). Bridging the specialty gap: Update on primary cutaneous lymphomas. Journal of the American Academy of Dermatology, 90(2), 257–260. https://doi.org/10.1016/j.jaad.2023.10.007

Geskin, L., Querfeld, C., Hodak, E., Nikbakht, N., Papadavid, E., Ardigò, M., Wehkamp, U., & Bagot, M. (2024). Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1298988

Shih, B. B., Ma, C., Cortes, J. R., Reglero, C., Miller, H., Quinn, S. A., Albero, R., Laurent, A. P., Mackey, A., Ferrando, A. A., Geskin, L., & Palomero, T. (2024). Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology, 144(7), 1579-1589.e8. https://doi.org/10.1016/j.jid.2023.12.010

Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Gordon, E. R., Kwinta, B. D., & Geskin, L. J. (2023). Accessibility and readability of online patient education on cutaneous lymphomas. JAAD International, 13, 83–90. https://doi.org/10.1016/j.jdin.2023.07.010

Lin, W.-H. W., Rodriguez Cortes, J., Aitken, M., Reglero, C., Laurent, A., Cooke, A., Belver, L., Bhagat, G., Rabadan, R., Ferrando, A. A., & Palomero, T. (2023). Role of the S1P Signaling Pathway in the Pathogenesis of Angioimmunoblastic T-Cell Lymphoma. Blood, 142(Supplement 1), 526–526. https://doi.org/10.1182/blood-2023-174090

Bagot, M., Kim, Y. H., Geskin, L. J., Ortiz-Romero, P. L., Kim, E., Mehta-Shah, N., Dereure, O., Oro, S., Beylot-Barry, M., Dalle, S., Jacobsen, E., Lansigan, F., Ram-Wolff, C., Khodadoust, M. S., Battistella, M., Gru, A. A., Moins-Teisserenc, H., Zinzani, P. L., Viotti, J., … Porcu, P. (2023). Lacutamab in Patients with Relapsed and Refractory Sèzary Syndrome: Results from the Tellomak Phase 2 Trial. Blood, 142(Supplement 1), 185–185. https://doi.org/10.1182/blood-2023-173806

Fahmy, L. M., Yang, H. R., Zhou, M., Beylergil, V., Schreidah, C. M., Bilgrami, Z., Kwinta, B. D., Schwartz, L., Fojo, A. T., Bates, S. E., & Geskin, L. J. (2023). Dynamic Changes in Lymph Node Size and Skin Scoring Predict Response to Treatment in CTCL: An Interim Analysis. Blood, 142(Supplement 1), 4443–4443. https://doi.org/10.1182/blood-2023-189493

Tolu, S. S., Gribbin, C., Seshadri, M. R., Chen, Z., Orlando, E., Grenet, J., Toor, R., Sanjurjo, A., Phillips, A. A., Shore, T. B., Martin, P., Leonard, J. P., Pro, B., Amengual, J. E., & Ruan, J. (2023). Outcomes of Contemporary Novel Agent and Stem Cell Transplantation in Relapsed/Refractory PTCL. Blood, 142(Supplement 1), 1698–1698. https://doi.org/10.1182/blood-2023-178231

Schreidah, C. M., DeStephano, D. M., Pan, S. S., Wang, S., Shen, H., Ta, C. N., Reynolds, G. B., Fahmy, L. M., Gordon, E. R., Adeuyan, O., Kwinta, B. D., Stonesifer, C. J., Chan, W. H., Choi, J., Duvic, M., Gallardo, F., Girardi, M., Guitart, J., Kim, Y. H., … Geskin, L. J. (2023). Machine Learning-Based Survival Analysis Reveals Prognostic Clinical and Genetic Insights for Patients with Cutaneous T-Cell Lymphoma. Blood, 142(Supplement 1), 1715–1715. https://doi.org/10.1182/blood-2023-190775

Adeuyan, O., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Fahmy, L. M., Chen, C., & Geskin, L. J. (2023). 254 Cutaneous T-cell lymphoma and atopic dermatitis: a tale of two inflammatory skin conditions from a single cell RNA sequencing perspective. Journal of Investigative Dermatology, 143(11), S375. https://doi.org/10.1016/j.jid.2023.09.262

Fahmy, L. M., Schreidah, C. M., Lapolla, B. A., Magro, C. M., & Geskin, L. J. (2023). Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis. JAAD Case Reports, 41, 85–89. https://doi.org/10.1016/j.jdcr.2023.08.049

Geskin, L. J., Angello, J. T., Bagot, M., Guenova, E., Nikbakht, N., Querfeld, C., & Scarisbrick, J. J. (2024). Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences. Clinical Lymphoma Myeloma and Leukemia, 24(1), 40–47. https://doi.org/10.1016/j.clml.2023.08.020

Fahmy, L. M., Yang, H. R., Zhou, M., Beylergil, V., Schreidah, C. M., Kwinta, B. D., Schwartz, L. H., Fojo, A. T., Bates, S. E., & Geskin, L. J. (2023). LYMPH NODE AND SKIN SCORING GROWTH KINETICS PREDICT OUTCOMES IN CUTANEOUS T‐CELL LYMPHOMA: AN INTERIM ANALYSIS. Hematological Oncology, 41(S2), 772–772. Portico. https://doi.org/10.1002/hon.3165_619

Geskin, L. J., Kwinta, B. D., Garcia-Saleem, T. J., Akilov, O. E., Enz, P. A., Guenova, E., Ortiz-Romero, P. L., Papadavid, E., Quaglino, P., Rozati, S., Stonesifer, C. J., Burns, A., Stringer, W. S., Tarin, E., & Scarisbrick, J. J. (2023). International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study. Journal of the American Academy of Dermatology, 88(4), 935–937. https://doi.org/10.1016/j.jaad.2022.11.016

Fahmy, L. M., Kwinta, B. D., Schreidah, C. M., Ferris, L. K., & Geskin, L. J. (2022). Topical Mechlorethamine for the Treatment of Psoriasis: A Report of Two Cases and Literature Review. Dermatology and Therapy, 13(2), 617–627. https://doi.org/10.1007/s13555-022-00871-2

Shim, J., Park, J., Abudureyimu, G., Kim, M.-H., Shim, J. S., Jang, K.-T., Kwon, E. J., Jang, H.-S., Yeo, E., Lee, J. H., & Lee, D. (2022). Comparative Spatial Transcriptomic and Single-Cell Analyses of Human Nail Units and Hair Follicles Show Transcriptional Similarities between the Onychodermis and Follicular Dermal Papilla. Journal of Investigative Dermatology, 142(12), 3146-3157.e12. https://doi.org/10.1016/j.jid.2022.06.022

Fahmy, L., Yang, H. R., Kwinta, B., Beylergil, V., Schreidah, C. M., Schwartz, L. H., & Geskin, L. J. (2022). Evaluation of Volumetric Lymph Node Measurements in Cutaneous T-Cell Lymphoma Patients Enrolled in the Mavoric Trial: An Interim Analysis. Blood, 140(Supplement 1), 3700–3700. https://doi.org/10.1182/blood-2022-163711

Prince, H. M. M., Geskin, L. J., Akilov, O. E., Kuzel, T. M., Querfeld, C., Ooi, C. E., Xing, D., Sauter, N., Singh, P., Czuczman, M., & Foss, F. M. (2022). Safety and Tolerability of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302. Blood, 140(Supplement 1), 6577–6578. https://doi.org/10.1182/blood-2022-167564

Savage, K. J., Horwitz, S. M., Advani, R., Christensen, J. H., Domingo-Domenech, E., Rossi, G., Morschhauser, F., Alpdogan, O., Suh, C., Tobinai, K., Shustov, A., Trneny, M., Yuen, S., Zinzani, P. L., Trümper, L., Ilidge, T., O’Connor, O. A., Pro, B., Miao, H., … Iyer, S. (2022). Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood Advances, 6(19), 5550–5555. https://doi.org/10.1182/bloodadvances.2020003971

Kwinta, B. D., Khan, S., Carvajal, R., Izar, B., Queen, D., Garcia-Saleem, T., & Geskin, L. (2022). LB939 Novel recommendations to minimize cSCC risk in SOTR. Journal of Investigative Dermatology, 142(8), B16. https://doi.org/10.1016/j.jid.2022.05.958

Gaydosik, A. M., Stonesifer, C. J., Khaleel, A. E., Geskin, L. J., & Fuschiotti, P. (2022). Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas. Clinical Cancer Research, 28(12), 2610–2622. https://doi.org/10.1158/1078-0432.ccr-21-4437

Pemmaraju, N., Cuglievan, B., Lasky, J., Kheradpour, A., Hijiya, N., Stein, A. S., Meshinchi, S., Mullen, C., Angelucci, E., Vinti, L., Mughal, T. I., & Pawlowska, A. (2022). P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY. HemaSphere, 6, 420–421. https://doi.org/10.1097/01.hs9.0000844972.31512.dd